COVID-19 EN PANAMÁ Y EL MUNDO: UNA REVISIÓN DE LA LITERATURA

René Rivera; María Ramírez; Alicia Rodríguez; Jorge Hernández

Enviado octubre 26, 2024

Publicado 2026-02-02

Artículos de Investigación

Vol. 32 (2019): Revista Médico Científica

COVID-19 EN PANAMÁ Y EL MUNDO: UNA REVISIÓN DE LA LITERATURA

René Rivera⁺⁻
María Ramírez⁺⁻
Alicia Rodríguez⁺⁻
Jorge Hernández⁺⁻

PDF

Citación:

DOI: ND

Publicado: 2026-02-02

Derechos de autor 2024 Revista médico científica

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Resumen

ANTECEDENTES: El virus SARS-CoV-2, causante de la Enfermedad por Coronavirus del2019 (COVID-19) emergió en Wuhan, China, en diciembre de 2019, y tiene una extensión global actualmente. Su fisiopatología, distribución geográfica y características clínicas son objetosde análisiscontinuo con resultados prometedores, pero difíciles de reunir y sintetizar considerando las numerosas y heterogéneas fuentes de información y el dinamismo de la curva epidemiológica de esta pandemia.

OBJETIVO: Sintetizar la literatura actual sobre la pandemia del COVID-19, con el propósito de establecer de forma transparente y concisa la información de origen nacional e internacional disponible, para que sirva como una fuente confiable de la evidencia publicada.

DISEÑO: Se utilizaron artículos científicos publicados entre diciembre de 2019 y abrilde 2020, que fueron seleccionados por su relevancia, validez y calidad de contenido, como aquellos disponibles en elNew England Journal of Medicine, Journal of the American Medical Association, The Lancety el British Medical Journal, obtenidos a través de las bibliotecas virtuales de estas revistas científicasademás de la información proporcionada por instituciones reconocidas a nivel mundial en sus páginas web oficiales, como lo son la Organización Mundial de la Salud, el Centro para el Control y Prevención de Enfermedades y la Universidad de John Hopkins.

CONCLUSIÓN: La información actual sobre la pandemia del SARS-CoV-2 está renovándose continuamente y se espera que continúe haciéndolo por los próximos meses. Se torna complicado el mantenerse actualizado, por lo cual confiamos en que esta revisión será útil para distintos estudiantes y profesionales de la salud.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Arturo Rodríguez-Sabogal I, Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infectio. 2020;24(3):57–62. DOI: 10.22354/in.v24i3.848.
Ministerio de Salud de la República de Panamá. Casos de Coronavirus COVID-19 en Panamá [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: http://minsa.gob.pa/coronavirus-covid19.
del Rio C, Malani PN. COVID-19—New Insights on a Rapidly Changing Epidemic. JAMA. 2020;323(14):1339–1340. DOI: 10.1001/jama.2020.3072.
Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–1720. DOI: 10.1056/NEJMoa2002032.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648.
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA. 2020. DOI: 10.1001/jamainternmed.2020.0994.
Organización Mundial de la Salud. Infecciones por coronavirus [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: http://www9.who.int/csr/disease/coronavirus_infections/es/.
Johns Hopkins Coronavirus Resource Center. Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins [Internet]. 2020 [citado el 28 de marzo de 2020]. Disponible en: https://coronavirus.jhu.edu/map.html.
Pan American Health Association. Coronavirus Disease (COVID-19) [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: https://www.paho.org/en/topics/coronavirus-infections/coronavirus-disease-covid-19.
Ministerio de Salud de la República de Panamá. Panamá confirma primer caso de COVID-19 [Internet]. 2020 [citado el 21 de abril de 2020]. Disponible en: http://www.minsa.gob.pa/noticia/panama-confirma-primer-caso-de-covid-19.
Center for Disease Control and Prevention. Human Coronavirus Types [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: https://www.cdc.gov/coronavirus/types.html.
John Hopkins Center of Health Security. Coronaviruses: SARS, MERS, and 2019-nCoV [Internet]. 2020 [citado el 26 de marzo de 2020]. Disponible en: http://www.centerforhealthsecurity.org/resources/fact-sheets/pdfs/coronaviruses.pdf.
Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020;91:264–266. DOI: 10.1016/j.ijid.2020.01.009.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109. DOI: 10.1016/j.jaut.2020.102433.
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents. 2020;55(3). DOI: 10.1016/j.ijantimicag.2020.105924.
Ma X, Wang D, Xu W, Wu G, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. DOI: 10.1056/NEJMoa2001017.
Zhoua D, Zhang P, Baoa C, Zhanga Y, Zhu N. Emerging Understanding of Etiology and Epidemiology of the Novel Coronavirus (COVID-19) infection in Wuhan, China. Preprints. 2020. DOI: 10.20944/preprints202002.0283.v1.
Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020;9(3):231. DOI: 10.3390/pathogens9030231.
Doremalen N, Morris D, Holbrook M, Gamble A, Williamson B. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382:1177–1179. DOI: 10.1056/NEJMc2001737.
Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):1–4. DOI: 10.1093/jtm/taaa021.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020; 323(14):1406–1407. DOI: 10.1001/jama.2020.2565.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. DOI: 10.1016/S0140-6736(20)30628-0.
Cao X. COVID-19: immunopathology and its implications for therapy. Nature Reviews Immunology. 2020;20:269–270. DOI: 10.1038/s41577-020-0308-3.
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology. 2020;38(1):1–9. DOI: 10.12932/AP-200220-0772.
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. DOI: 10.1007/s00134-020-05991-x.
Bertran Recasens B, Martinez?Llorens JM, Rodriguez?Sevilla JJ, Rubio MA. Lack of dyspnea in Covid?19 patients; another neurological conundrum? Eur J Neurol. 2020. DOI: 10.1111/ene.14265.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China. Am J Gastroenterol. 2020;115(5):766–773. DOI: 10.14309/ajg.0000000000000620.
Donovan O, Tanveer S, Jones N, Hopkins C, Senior BA, Wise SK, et al. What is the evidence for anosmia (loss of smell) as a clinical feature of COVID-19? [Internet]. Centre for Evidence-Based Medicine. 2020 [citado el 2 de abril de 2020]. Disponible en: https://www.cebm.net/covid-19/what-is-the-evidence-for-anosmia-loss-of-smell-as-a-clinical
Toscano G, Palmerini F, Ravaglia S, Ruiz L. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020. DOI: 10.1056/NEJMc2009191.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. DOI: 10.1016/S0140-6736(20)30937-5.
Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020; 382:1663–1665. DOI: 10.1056/NEJMc2005073.
Reyna R. Valoración por Imagen de la Neumonía por COVID-19: Conceptos Básicos. Sociedad Panameña de Radiología e Imagen. 2020.
Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020. DOI: 10.1007/s00134-020-06033-2.
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol. 2020. DOI: 10.1016/j.jtho.2020.02.010.
Johns Hopkins Center of Health Security. Diagnostic Testing for 2019-nCoV [Internet]. 2020 [citado el 28 de marzo de 2020]. Disponible en: http://www.centerforhealthsecurity.org/resources/COVID-19/200130-nCoV-diagnostics-factsheet.pdf.
Johns Hopkins Center of Health Security. Serology testing for COVID-19 [Internet]. 2020 [citado el 28 de marzo de 2020]. Disponible en: http://www.centerforhealthsecurity.org/resources/COVID-19/200228-Serology-testing-COVID.pdf.
Centers for Disease Control and Prevention. Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) [Internet]. 2020 [citado el 29 de marzo de 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html.
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020. DOI: 10.1001/jama.2020.3786.
SEIP, APNCT, ASPAMI, SPARA, SPMI, ASPAME, SPR, APAIC, APG, APMCTI, APN, SPNH, SPRI, APCO, SPP, SPO, SPOG, SPPNA, SPH, SPC, APGED, SPOCC, SPP. Guías Nacionales de Atención de Pacientes Adultos COVID-19. Panamá; 2 de abril 2020. Versión 3.0.
Centers for Disease Control and Prevention. Information for Clinicians on Therapeutic Options for COVID-19 Patients [Internet]. 2020 [citado el 26 de marzo de 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html.
Organización Mundial de la Salud. Global research on coronavirus disease (COVID-19) [Internet]. 2020 [citado el 29 de marzo de 2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov
Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. 2020. DOI: 10.1016/j.ijantimicag.2020.105949
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. DOI: 10.1016/s0140-6736(20)30566-3
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020. DOI: 10.1056/NEJMoa2001282
Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. DOI: 10.1016/S0140-6736(20)30628-0
Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective Treatment of Severe COVID-19 Patients with Tocilizumab. 2020. DOI: chinaXiv:202003.00026v1
Furuta Y, Komeno T, Nakamuba T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449–463. DOI: 10.2183/pjab.93.027
Aukrust P, Barratt-Due A, Kasine T, Nezvalova-Henriksen K, Dyrhol Riise AM, Troseid M, et al. The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2 [Internet]. NIH ClinicalTrials.gov. 2020 [citado el 2 de abril de 2020]. Disponible en: https://clinicaltrials.gov/ct2/show/NCT04321616?recrs=abdfm&cond=COVID-19&draw=10&rank=89
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. DOI: 10.1001/jamacardio.2020.1017
Lippi G, Plebani M, Michael Henry B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148. DOI: 10.1016/j.cca.2020.03.022
Lai C-C, Wang C-Y, Wang Y-H, Hsueh S-C, Ko W-C, Hsueh P-R. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. International Journal of Antimicrobial Agents. 2020;55(4). DOI: 10.1016/j.ijantimicag.2020.105946
Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020; 10. DOI: 10.1186/s13613-020-00650-2
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis. 2020; 18(5):1094–1099. DOI: 10.1111/JTH.14817
Cao Q, Chen YC, Chen CL, Chiu CH. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. Journal of the Formosan Medical Association. 2020; 119(3):670–673. DOI: 10.1016/j.jfma.2020.02.009
Organización Mundial de la Salud. Bacille Calmette-Guérin (BCG) vaccination and COVID-19 [Internet]. 2020 [citado el 2 de mayo de 2020]. Disponible en: https://www.who.int/news-room/commentaries/detail/bacille-calmette-guérin-(bcg)-vaccination-and-covid-19
Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Heal. 2020; 8(4). DOI: 10.1016/S2214-109X(20)30068-1
Cowling BJ, Aiello A. Public health measures to slow community spread of COVID-19. J Infect Dis. 2020. DOI: 10.1093/infdis/jiaa123
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection. 2020; 104(3):246–251. DOI: 10.1016/j.jhin.2020.01.022
Feng S, Shen C, Xia N, Song W, Fan M, Cowling BJ. Rational use of face masks in the COVID-19 pandemic. Lancet Respiratory Medicine. 2020. DOI: 10.1016/S2213-2600(20)30134-X
Center for Disease Control and Prevention. How to Protect Yourself and others [Internet]. 2020 [citado el 21 de abril de 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
Radonovich LJ, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA, et al. N95 respirators vs medical masks for preventing influenza among health care personnel: A randomized clinical trial. JAMA. 2019;322(9):824–833. DOI: 10.1001/jama.2019.11645
Xiao J, Shiu EYC, Gao H, Wong JY, Fong MW, Ryu S, et al. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures. Emerging Infectious Diseases. 2020;26(5). DOI: 10.3201/eid2605.190994
Ebrahim SH, Memish ZA. COVID-19 – the role of mass gatherings. Travel Med Infect Dis. 2020. DOI: 10.1016/j.tmaid.2020.101617
Wei C, Qing W, Yuanqiu L, Hailiang Y, Yinyin X, Muli Z, et al. Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China. Chinese J Prev Med. 2020;54(3):1–6. DOI: 10.3760/cma.j.issn.0253-9624.2020.03.003
Kissler S, Tedijanto C, Lipsitch M, Grad YH. Social distancing strategies for curbing the COVID-19 epidemic. 2020. DOI: 10.1101/2020.03.22.20041079
Peak CM, Kahn R, Grad YH, Childs LM, Li R, Lipsitch M, et al. Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19. 2020. DOI: 10.1101/2020.03.05.20031088
Organización Panamericana de la Salud. Inteligencia artificial, la herramienta de Panamá para contener el COVID-19 [Internet]. 2020 [citado el 2 de abril de 2020]. Disponible en: https://www.paho.org/pan/index.php?option=com_content&view=article&id=1355:inteligencia-artificial-la-herramienta-de-panama-para-contener-el-covid-19&Itemid=442
Ministerio de Salud de la República de Panamá. Los seis anillos del “Plan Protégete Panamá” [Internet]. 2020 [citado el 2 de abril de 2020]. Disponible en: http://www.minsa.gob.pa/noticia/los-seis-anillos-del-plan-protegete-panama
Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet J-C, et al. SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF. Gynecol Obstet Fertil Senol. 2020;48(5):436–443. DOI: 10.1016/j.gofs.2020.03.014
Dashraath P, Jing Lin Jeslyn W, Mei Xian Karen L, Li Min L, Sarah L, Biswas A, et al. Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. Am J Obstet Gynecol. 2020. DOI: 10.1016/j.ajog.2020.03.021
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815. DOI: 10.1016/S0140-6736(20)30360-3
Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational Pediatrics. 2020; 9(1). DOI: 10.21037/tp.2020.02.06
Chen D, Yang H, Cao Y, Cheng W, Duan T, Fan C, et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynaecol Obstet. 2020; 149(2):130-136. DOI: 10.1002/ijgo.13146
Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. DOI: 10.1016/S0140-6736(20)30154-9
Zheng F, Liao C, Fan Q, Chen H, Zhao X, Xie Z, et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–280. DOI: 10.1007/s11596-020-2172-6
Ludvigsson JF. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatrica. 2020. DOI: 10.1111/apa.15270
Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel Coronavirus Infection in Hospitalized Infants under 1 Year of Age in China. JAMA. 2020; 323(13):1313–1314. DOI: 10.1001/jama.2020.2131
Fukuda K, World Health Organization Global Influenza Programme. Pandemic influenza preparedness and response: a WHO guidance document. [Internet]. 2009 [citado el 30 de marzo de 2020]. Disponible en: https://www.who.int/influenza/resources/pip_framework/es/
Magal P, Webb G. Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany. 2020. DOI: 10.1101/2020.03.21.20040154
Roques L, Klein E, Papaïx JP, Soubeyrand S. Mechanistic-statistical SIR modelling for early estimation of the actual number of cases and mortality rate from COVID-19. 2020. DOI: 10.1101/2020.03.22.20040915
Kraemer MUG, Yang C-H, Gutierrez B, Wu C-H, Klein B, Pigott DM, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020; 368(6490):493–497. DOI: 10.1126/science.abb4218
Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period. Science. 2020. DOI: 10.1126/science.abb5793

Palabras clave

PDF

Resumen visto - 6 veces
PDF descargado - 1

Licencia

Content Top

[1] Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Arturo Rodríguez-Sabogal I, Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infectio. 2020;24(3):57–62. DOI: 10.22354/in.v24i3.848.

[2] Ministerio de Salud de la República de Panamá. Casos de Coronavirus COVID-19 en Panamá [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: http://minsa.gob.pa/coronavirus-covid19.

[3] del Rio C, Malani PN. COVID-19—New Insights on a Rapidly Changing Epidemic. JAMA. 2020;323(14):1339–1340. DOI: 10.1001/jama.2020.3072.

[4] Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–1720. DOI: 10.1056/NEJMoa2002032.

[5] Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648.

[6] Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA. 2020. DOI: 10.1001/jamainternmed.2020.0994.

[7] Organización Mundial de la Salud. Infecciones por coronavirus [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: http://www9.who.int/csr/disease/coronavirus_infections/es/.

[8] Johns Hopkins Coronavirus Resource Center. Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins [Internet]. 2020 [citado el 28 de marzo de 2020]. Disponible en: https://coronavirus.jhu.edu/map.html.

[9] Pan American Health Association. Coronavirus Disease (COVID-19) [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: https://www.paho.org/en/topics/coronavirus-infections/coronavirus-disease-covid-19.

[10] Ministerio de Salud de la República de Panamá. Panamá confirma primer caso de COVID-19 [Internet]. 2020 [citado el 21 de abril de 2020]. Disponible en: http://www.minsa.gob.pa/noticia/panama-confirma-primer-caso-de-covid-19.

[11] Center for Disease Control and Prevention. Human Coronavirus Types [Internet]. 2020 [citado el 27 de marzo de 2020]. Disponible en: https://www.cdc.gov/coronavirus/types.html.

[12] John Hopkins Center of Health Security. Coronaviruses: SARS, MERS, and 2019-nCoV [Internet]. 2020 [citado el 26 de marzo de 2020]. Disponible en: http://www.centerforhealthsecurity.org/resources/fact-sheets/pdfs/coronaviruses.pdf.

[13] Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020;91:264–266. DOI: 10.1016/j.ijid.2020.01.009.

[14] Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109. DOI: 10.1016/j.jaut.2020.102433.

[15] Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents. 2020;55(3). DOI: 10.1016/j.ijantimicag.2020.105924.

[16] Ma X, Wang D, Xu W, Wu G, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. DOI: 10.1056/NEJMoa2001017.

[17] Zhoua D, Zhang P, Baoa C, Zhanga Y, Zhu N. Emerging Understanding of Etiology and Epidemiology of the Novel Coronavirus (COVID-19) infection in Wuhan, China. Preprints. 2020. DOI: 10.20944/preprints202002.0283.v1.

[18] Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020;9(3):231. DOI: 10.3390/pathogens9030231.

[19] Doremalen N, Morris D, Holbrook M, Gamble A, Williamson B. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382:1177–1179. DOI: 10.1056/NEJMc2001737.

[20] Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):1–4. DOI: 10.1093/jtm/taaa021.

[21] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.

[22] Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020; 323(14):1406–1407. DOI: 10.1001/jama.2020.2565.

[23] Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. DOI: 10.1016/S0140-6736(20)30628-0.

[24] Cao X. COVID-19: immunopathology and its implications for therapy. Nature Reviews Immunology. 2020;20:269–270. DOI: 10.1038/s41577-020-0308-3.

[25] Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology. 2020;38(1):1–9. DOI: 10.12932/AP-200220-0772.

[26] Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. DOI: 10.1007/s00134-020-05991-x.

[27] Bertran Recasens B, Martinez?Llorens JM, Rodriguez?Sevilla JJ, Rubio MA. Lack of dyspnea in Covid?19 patients; another neurological conundrum? Eur J Neurol. 2020. DOI: 10.1111/ene.14265.

[28] Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China. Am J Gastroenterol. 2020;115(5):766–773. DOI: 10.14309/ajg.0000000000000620.

[29] Donovan O, Tanveer S, Jones N, Hopkins C, Senior BA, Wise SK, et al. What is the evidence for anosmia (loss of smell) as a clinical feature of COVID-19? [Internet]. Centre for Evidence-Based Medicine. 2020 [citado el 2 de abril de 2020]. Disponible en: https://www.cebm.net/covid-19/what-is-the-evidence-for-anosmia-loss-of-smell-as-a-clinical

[30] Toscano G, Palmerini F, Ravaglia S, Ruiz L. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020. DOI: 10.1056/NEJMc2009191.

[31] Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. DOI: 10.1016/S0140-6736(20)30937-5.

[32] Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020; 382:1663–1665. DOI: 10.1056/NEJMc2005073.

[33] Reyna R. Valoración por Imagen de la Neumonía por COVID-19: Conceptos Básicos. Sociedad Panameña de Radiología e Imagen. 2020.

[34] Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020. DOI: 10.1007/s00134-020-06033-2.

[35] Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol. 2020. DOI: 10.1016/j.jtho.2020.02.010.

[36] Johns Hopkins Center of Health Security. Diagnostic Testing for 2019-nCoV [Internet]. 2020 [citado el 28 de marzo de 2020]. Disponible en: http://www.centerforhealthsecurity.org/resources/COVID-19/200130-nCoV-diagnostics-factsheet.pdf.

[37] Johns Hopkins Center of Health Security. Serology testing for COVID-19 [Internet]. 2020 [citado el 28 de marzo de 2020]. Disponible en: http://www.centerforhealthsecurity.org/resources/COVID-19/200228-Serology-testing-COVID.pdf.

[38] Centers for Disease Control and Prevention. Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) [Internet]. 2020 [citado el 29 de marzo de 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html.

[39] Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020. DOI: 10.1001/jama.2020.3786.

[40] SEIP, APNCT, ASPAMI, SPARA, SPMI, ASPAME, SPR, APAIC, APG, APMCTI, APN, SPNH, SPRI, APCO, SPP, SPO, SPOG, SPPNA, SPH, SPC, APGED, SPOCC, SPP. Guías Nacionales de Atención de Pacientes Adultos COVID-19. Panamá; 2 de abril 2020. Versión 3.0.

[41] Centers for Disease Control and Prevention. Information for Clinicians on Therapeutic Options for COVID-19 Patients [Internet]. 2020 [citado el 26 de marzo de 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html.

[42] Organización Mundial de la Salud. Global research on coronavirus disease (COVID-19) [Internet]. 2020 [citado el 29 de marzo de 2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov

[43] Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. 2020. DOI: 10.1016/j.ijantimicag.2020.105949

[44] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. DOI: 10.1016/s0140-6736(20)30566-3

[45] Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020. DOI: 10.1056/NEJMoa2001282

[46] Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. DOI: 10.1016/S0140-6736(20)30628-0

[47] Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective Treatment of Severe COVID-19 Patients with Tocilizumab. 2020. DOI: chinaXiv:202003.00026v1

[48] Furuta Y, Komeno T, Nakamuba T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449–463. DOI: 10.2183/pjab.93.027

[49] Aukrust P, Barratt-Due A, Kasine T, Nezvalova-Henriksen K, Dyrhol Riise AM, Troseid M, et al. The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2 [Internet]. NIH ClinicalTrials.gov. 2020 [citado el 2 de abril de 2020]. Disponible en: https://clinicaltrials.gov/ct2/show/NCT04321616?recrs=abdfm&cond=COVID-19&draw=10&rank=89

[50] Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. DOI: 10.1001/jamacardio.2020.1017

[51] Lippi G, Plebani M, Michael Henry B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148. DOI: 10.1016/j.cca.2020.03.022

[52] Lai C-C, Wang C-Y, Wang Y-H, Hsueh S-C, Ko W-C, Hsueh P-R. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. International Journal of Antimicrobial Agents. 2020;55(4). DOI: 10.1016/j.ijantimicag.2020.105946

[53] Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020; 10. DOI: 10.1186/s13613-020-00650-2

[54] Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis. 2020; 18(5):1094–1099. DOI: 10.1111/JTH.14817

[55] Cao Q, Chen YC, Chen CL, Chiu CH. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. Journal of the Formosan Medical Association. 2020; 119(3):670–673. DOI: 10.1016/j.jfma.2020.02.009

[56] Organización Mundial de la Salud. Bacille Calmette-Guérin (BCG) vaccination and COVID-19 [Internet]. 2020 [citado el 2 de mayo de 2020]. Disponible en: https://www.who.int/news-room/commentaries/detail/bacille-calmette-guérin-(bcg)-vaccination-and-covid-19

[57] Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Heal. 2020; 8(4). DOI: 10.1016/S2214-109X(20)30068-1

[58] Cowling BJ, Aiello A. Public health measures to slow community spread of COVID-19. J Infect Dis. 2020. DOI: 10.1093/infdis/jiaa123

[59] Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection. 2020; 104(3):246–251. DOI: 10.1016/j.jhin.2020.01.022

[60] Feng S, Shen C, Xia N, Song W, Fan M, Cowling BJ. Rational use of face masks in the COVID-19 pandemic. Lancet Respiratory Medicine. 2020. DOI: 10.1016/S2213-2600(20)30134-X

[61] Center for Disease Control and Prevention. How to Protect Yourself and others [Internet]. 2020 [citado el 21 de abril de 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html

[62] Radonovich LJ, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA, et al. N95 respirators vs medical masks for preventing influenza among health care personnel: A randomized clinical trial. JAMA. 2019;322(9):824–833. DOI: 10.1001/jama.2019.11645

[63] Xiao J, Shiu EYC, Gao H, Wong JY, Fong MW, Ryu S, et al. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures. Emerging Infectious Diseases. 2020;26(5). DOI: 10.3201/eid2605.190994

[64] Ebrahim SH, Memish ZA. COVID-19 – the role of mass gatherings. Travel Med Infect Dis. 2020. DOI: 10.1016/j.tmaid.2020.101617

[65] Wei C, Qing W, Yuanqiu L, Hailiang Y, Yinyin X, Muli Z, et al. Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China. Chinese J Prev Med. 2020;54(3):1–6. DOI: 10.3760/cma.j.issn.0253-9624.2020.03.003

[66] Kissler S, Tedijanto C, Lipsitch M, Grad YH. Social distancing strategies for curbing the COVID-19 epidemic. 2020. DOI: 10.1101/2020.03.22.20041079

[67] Peak CM, Kahn R, Grad YH, Childs LM, Li R, Lipsitch M, et al. Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19. 2020. DOI: 10.1101/2020.03.05.20031088

[68] Organización Panamericana de la Salud. Inteligencia artificial, la herramienta de Panamá para contener el COVID-19 [Internet]. 2020 [citado el 2 de abril de 2020]. Disponible en: https://www.paho.org/pan/index.php?option=com_content&view=article&id=1355:inteligencia-artificial-la-herramienta-de-panama-para-contener-el-covid-19&Itemid=442

[69] Ministerio de Salud de la República de Panamá. Los seis anillos del “Plan Protégete Panamá” [Internet]. 2020 [citado el 2 de abril de 2020]. Disponible en: http://www.minsa.gob.pa/noticia/los-seis-anillos-del-plan-protegete-panama

[70] Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet J-C, et al. SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF. Gynecol Obstet Fertil Senol. 2020;48(5):436–443. DOI: 10.1016/j.gofs.2020.03.014

[71] Dashraath P, Jing Lin Jeslyn W, Mei Xian Karen L, Li Min L, Sarah L, Biswas A, et al. Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. Am J Obstet Gynecol. 2020. DOI: 10.1016/j.ajog.2020.03.021

[72] Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815. DOI: 10.1016/S0140-6736(20)30360-3

[73] Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational Pediatrics. 2020; 9(1). DOI: 10.21037/tp.2020.02.06

[74] Chen D, Yang H, Cao Y, Cheng W, Duan T, Fan C, et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynaecol Obstet. 2020; 149(2):130-136. DOI: 10.1002/ijgo.13146

[75] Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. DOI: 10.1016/S0140-6736(20)30154-9

[76] Zheng F, Liao C, Fan Q, Chen H, Zhao X, Xie Z, et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–280. DOI: 10.1007/s11596-020-2172-6

[77] Ludvigsson JF. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatrica. 2020. DOI: 10.1111/apa.15270

[78] Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel Coronavirus Infection in Hospitalized Infants under 1 Year of Age in China. JAMA. 2020; 323(13):1313–1314. DOI: 10.1001/jama.2020.2131

[79] Fukuda K, World Health Organization Global Influenza Programme. Pandemic influenza preparedness and response: a WHO guidance document. [Internet]. 2009 [citado el 30 de marzo de 2020]. Disponible en: https://www.who.int/influenza/resources/pip_framework/es/

[80] Magal P, Webb G. Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany. 2020. DOI: 10.1101/2020.03.21.20040154

[81] Roques L, Klein E, Papaïx JP, Soubeyrand S. Mechanistic-statistical SIR modelling for early estimation of the actual number of cases and mortality rate from COVID-19. 2020. DOI: 10.1101/2020.03.22.20040915

[82] Kraemer MUG, Yang C-H, Gutierrez B, Wu C-H, Klein B, Pigott DM, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020; 368(6490):493–497. DOI: 10.1126/science.abb4218

[83] Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period. Science. 2020. DOI: 10.1126/science.abb5793

Imagen de portada

Resumen

Descargas

Citas

Palabras clave

Licencia